#interferon — Thursday, January 01, 2026 (1 items)
| 0 | 💬 0 |
Elebsiran and PEG-IFNalpha for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial.
(nature.com)
|
Nature Medicine 2026-01-01 | #vaccination #immunity #rnai #hepatitis b #interferon |